The link between affective and functional gastrointestinal disorders: Are we solving the psychobiological puzzle?

Neurogastroenterology and Motility

Volumn 20, Issue 12, 2008, Pages 1265-1267

  Van Oudenhove, L ^a,b  

^a KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GAMMA INTERFERON; KYNURENINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

ANXIETY DISORDER; AUTONOMIC NERVOUS SYSTEM; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; EMOTIONALITY; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IRRITABLE COLON; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR FUNCTION; SEROTONINERGIC SYSTEM;

GASTROINTESTINAL DISEASES; HUMANS; MOOD DISORDERS;

EID: 56549095015     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01206.x     Document Type: Review

References (27)

1. Anand P, Aziz Q, Willert R, Van Oudenhove L. Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterol Motil 2007 19 (Suppl. 1 29 46.
2. Olden KW. Psychosocial factors in functional gastrointestinal disorders: an evolving phenomenon. Neurogastroenterol Motil 2008 20 : 114 20.
3. Mayer EA, Naliboff BD, Craig ADB. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006 131 : 25 42.
4. Mayer EA. Enteric neuroscience: the dawn of a new discipline. Gastroenterology 2007 132 : 1217 8.
5. Castle MZD, Silk DBA, Libby GW. The rationale for antidepressant therapy in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004 19 : 969 79.
6. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003 65 : 528 33.
7. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002 122 : 1140 56.
8. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol 2001 96 : 1072 9.
9. Fitzgerald P, Cassidy EM, Clarke G et al. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol Motil 2008 20 : 1291 7.
10. Nutt DJ. The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol 2002 17 : S1 12.
11. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006 27 : 24 31.
12. Booij L, Van der Does AJW, Riedel WJ. Monoamine depletion in psychiatric and healthy populations: review. Mol Psychiatry 2003 8 : 951 73.
13. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007 132 : 397 414.
14. Berman S, Chang L, Suyenobu B et al. Condition-specific deactivation of brain regions by 5-HT(3) receptor antagonist Alosetron. Gastroenterology 2002 123 : 969 77.
15. Kilkens TOC, Honig A, van Nieuwenhoven MA, Riedel WJ, Brummer R-JM. Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut 2004 53 : 1794 800.
16. Liebregts T, Adam B, Bredack C et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007 132 : 913 20.
17. Tack J, Broekaert D, Fischler B, Van Oudenhove L, Gevers AM, Janssens J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 2006 55 : 1095 103.
18. Claes SJ. Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology. Ann Med 2004 36 : 50 61.
19. Friedman BH, Thayer JF. Anxiety and autonomic flexibility: a cardiovascular approach. Biol Psychol 1998 47 : 243 63.
20. Tache Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007 117 : 33 40.
21. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998 42 : 845 9.
22. Posserud I, Agerforz P, Ekman R, Bjornsson ES, Abrahamsson H, Simren M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004 53 : 1102 8.
23. Bohmelt AH, Nater UM, Franke S, Hellhammer DH, Ehlert U. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 2005 67 : 288 94.
24. Dinan TG, Quigley EMM, Ahmed SMM et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006 130 : 304 11.
25. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006 6 : 318 28.
26. Damasio AR, Grabowski TJ, Bechara A et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci 2000 3 : 1049 56.
27. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003 65 : 193 207.